Surgery Partners (SGRY) earnings
In the quarter ended June 2026, Surgery Partners had revenue of $849M, up 2.7% on a year earlier, and diluted EPS of -0.12.
On August 10, 2026 it reported EPS of 0.07 against an estimate of -0.03 (beat).
The next report is expected on Monday, November 9, 2026 before the market opens, with EPS expected around -0.03.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Mon Nov 9, 2026 | Before open | -0.03 | — |
| Last | Mon Aug 10, 2026 | — | -0.03 | 0.07 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from Surgery Partners's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | $849M | +2.7% | -0.12 | — | 12.0% | 2026-08-10 |
| Mar 31, 2026 | $811M | +4.5% | -0.28 | — | 8.1% | 2026-05-05 |
| Dec 31, 2025 | $885M | +2.4% | — | — | 12.5% | 2026-03-02 |
| Sep 30, 2025 | $822M | +6.6% | -0.18 | — | 12.9% | 2025-11-10 |
| Jun 30, 2025 | $826M | +8.4% | -0.02 | — | 13.5% | 2025-08-05 |
| Mar 31, 2025 | $776M | +8.2% | -0.30 | — | 8.0% | 2025-05-12 |
| Dec 31, 2024 | $864M | +17.5% | — | — | 14.7% | 2025-03-07 |
| Sep 30, 2024 | $770M | +14.3% | -0.25 | — | 7.9% | 2024-11-12 |
| Jun 30, 2024 | $762M | +14.2% | -0.12 | -180.0% | 11.1% | 2024-08-06 |
| Mar 31, 2024 | $717M | +7.7% | -0.10 | — | 10.6% | 2024-05-07 |
| Dec 31, 2023 | $735M | +4.0% | — | — | 13.8% | 2024-02-26 |
| Sep 30, 2023 | $674M | +8.6% | -0.04 | — | 12.3% | 2023-11-07 |
Questions
When does Surgery Partners report earnings?
Surgery Partners's next earnings report is expected on November 9, 2026 before the market opens.
How did Surgery Partners do last quarter?
In the quarter ended June 2026, Surgery Partners had revenue of $849M, up 2.7% on a year earlier, and diluted EPS of -0.12.
From Surgery Partners's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.